US 12091440
IL2 and peptide-MHC complex fusion proteins and methods of use thereof
granted A61KA61K2039/505A61K2039/585
Quick answer
US patent 12091440 (IL2 and peptide-MHC complex fusion proteins and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K2039/505, A61K2039/585, A61K2239/50, A61K2239/55